江苏艾康生物医药研发有限公司 Company Information
Company Name:
Jiangsu Aikon Biopharmaceutical R&D Co.,Ltd
Tel:
025-58851090
Email:
2881759498@qq.com
Nationality:
China
WebSite:
www.aikonchem.com/
Product List:
13011
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
Product List
99911-04-3
26964-29-4
7726-34-3
164650-45-7
16669-59-3
861709-47-9
31482-56-1
202335-72-6
68514-74-9
142630-71-5
676560-74-0
65095-75-2
942398-84-7
13007-32-4
38444-13-2
1369011-12-0
859915-25-6
229621-74-3
69188-47-2
40106-14-7
1198286-10-0
848074-36-2
78183-34-3
1044598-79-9
852246-52-7
606-04-2
15306-17-9
1960445-63-9
2073066-52-9
11027-63-7
2093110-21-3
174800-18-1
2739829-00-4
933724-95-9
23491-49-8
175884-78-3
1261648-89-8
75708-92-8
1957283-54-3
94-01-9
60761-53-7
1189056-65-2
885280-26-2
69022-70-4
35543-41-0
27383-91-1
132922-37-3
25898-37-7
77600-79-4
443908-19-8
2095432-58-7
1226070-17-2
2455-05-2
472-11-7
2231664-31-4
276680-69-4
896460-83-6
3-Butyne-1,2-diol, 2-methyl-4-(trimethylsilyl)-
1822793-14-5
73606-19-6
3125-07-3
1527-97-5
107447-04-1
1060812-69-2
814-89-1
401792-87-8
1434053-27-6
1185179-33-2
70553-75-2
929568-98-9
1678539-02-0
1420804-57-4
1402232-85-2
2141969-56-2
18917-96-9
82238-92-4
23669-79-6
50480-99-4
1000025-07-9
1513879-21-4
1959551-26-8
85686-00-6
1100393-59-6
1216177-66-0
1781098-86-9
2383588-60-9
124709-72-4
2624118-90-5
1217759-04-0
162046-51-7
73751-06-1
1824414-35-8
90005-07-5
744-80-9
1234692-71-7
104968-58-3
1909325-93-4
2955561-64-3
39027-95-7
43217-28-3
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
Copyright 2007© ChemicalBook. All rights reserved.